Clinical Trial Update: Iloprost Therapy in Patients With Critical Limb Ischemia

View source ↗

Summary

A Bayer-sponsored clinical trial evaluating Iloprost therapy in patients with peripheral arterial disease, including those with critical limb ischemia, has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Arterial Disease

Drugs mentioned

• Ventavis (iloprost) (iloprost)

Snippet

Sponsor: Bayer | Conditions: Peripheral Arterial Disease | Status: COMPLETED